Neem Biotech present biofilm disruptor at BIO Boston 2018, to minimise antimicrobial resistance

Neem Biotech, a Wales based pharmaceutical biotech working in the field of novel antimicrobial research and development will present details of the company’s approach to minimising antimicrobial resistance through biofilm disruption at BIO Boston 2018.

Neem Biotech’s lead candidate is a first-in-class compound with a novel mechanism of action that is showing promise in managing persistent bacterial infections associated with biofilm forming bacteria such as Pseudomonas aeruginosa and Staphylococcus aureus. By disrupting the chemical signalling used by these bacteria to form biofilms, Neem’s candidate compound allows antibiotics to work more effectively and can minimise the impact of phenotypic antimicrobial resistance.

Dr. Graham Dixon, Neem Biotech’s CEO will be presenting the company’s details on Wednesday 6th June 2018.

Dr. Dixon said:

This is a great opportunity for us to share Neem’s vision and work with the biotech and pharma communities. We have come a long way over the past few years and are excited about the impact that compounds in our pipeline can have on people with persistent bacterial infections and hence on slowing the development of antimicrobial resistance”

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Neem Biotech. (2019, June 19). Neem Biotech present biofilm disruptor at BIO Boston 2018, to minimise antimicrobial resistance. News-Medical. Retrieved on October 05, 2024 from https://www.news-medical.net/news/20180607/Neem-Biotech-present-biofilm-disruptor-at-BIO-Boston-2018-to-minimise-antimicrobial-resistance.aspx.

  • MLA

    Neem Biotech. "Neem Biotech present biofilm disruptor at BIO Boston 2018, to minimise antimicrobial resistance". News-Medical. 05 October 2024. <https://www.news-medical.net/news/20180607/Neem-Biotech-present-biofilm-disruptor-at-BIO-Boston-2018-to-minimise-antimicrobial-resistance.aspx>.

  • Chicago

    Neem Biotech. "Neem Biotech present biofilm disruptor at BIO Boston 2018, to minimise antimicrobial resistance". News-Medical. https://www.news-medical.net/news/20180607/Neem-Biotech-present-biofilm-disruptor-at-BIO-Boston-2018-to-minimise-antimicrobial-resistance.aspx. (accessed October 05, 2024).

  • Harvard

    Neem Biotech. 2019. Neem Biotech present biofilm disruptor at BIO Boston 2018, to minimise antimicrobial resistance. News-Medical, viewed 05 October 2024, https://www.news-medical.net/news/20180607/Neem-Biotech-present-biofilm-disruptor-at-BIO-Boston-2018-to-minimise-antimicrobial-resistance.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Wound healing work presented at the RCP Innovation in Medicine Conference 2018 by Neem Biotech